Metraipolis › archive › dc_f32dada47e65
The influence of concomitant proton pump inhibitors use on treatment efficacy in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a… — Europe PMC PMID:41798943
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41798943
- DOI
- 10.3389/fimmu.2026.1717420
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T03:45:01.456Z
- SHA-256 of the archived text
9102aa453e1fe2676d5b6dfc55f5a200ba5974020a7b1e0ead020358daee64cd- Stable URL of this page
https://metraipolis.com/documento/dc_f32dada47e65
How to cite
The influence of concomitant proton pump inhibitors use on treatment efficacy in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a… — Europe PMC PMID:41798943 — Europe PMC (en), https://europepmc.org/article/MED/41798943 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f32dada47e65 (Metraipolis archive dc_f32dada47e65, sha256 9102aa453e1fe2676d5b6dfc55f5a200ba5974020a7b1e0ead020358daee64cd)
BibTeX
@misc{dcf32dada47e65,
title = {The influence of concomitant proton pump inhibitors use on treatment efficacy in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a… — Europe PMC PMID:41798943},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41798943},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f32dada47e65; sha256 9102aa453e1fe2676d5b6dfc55f5a200ba5974020a7b1e0ead020358daee64cd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798943. Agents can read the archived copy with the MCP tool read_document.